Sabra Healthcare REIT (NASDAQ:SBRA) CEO Sells 200,000 Shares

Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) CEO Richard Matros sold 200,000 shares of Sabra Healthcare REIT stock in a transaction on Tuesday, September 8th. The shares were sold at an average price of $20.83, for a total value of $4,166,000.00. Following the completion of the transaction, the chief executive officer owned 1,657,686 shares of the company’s stock, valued at approximately $34,529,599.38. This trade represents a 10.77% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Sabra Healthcare REIT Stock Down 0.1%

NASDAQ SBRA traded down $0.02 on Wednesday, hitting $20.79. 3,332,324 shares of the stock were exchanged, compared to its average volume of 1,900,442. The company has a market cap of $5.31 billion, a PE ratio of 79.96, a PEG ratio of 1.58 and a beta of 0.65. The company has a 50-day moving average price of $20.68 and a 200-day moving average price of $20.20. The company has a quick ratio of 3.07, a current ratio of 3.07 and a debt-to-equity ratio of 0.95. Sabra Healthcare REIT, Inc. has a fifty-two week low of $17.17 and a fifty-two week high of $22.77.

Sabra Healthcare REIT (NASDAQ:SBRA) last posted its earnings results on Monday, August 3rd. The real estate investment trust reported ($0.10) EPS for the quarter, missing analysts’ consensus estimates of $0.17 by ($0.27). Sabra Healthcare REIT had a net margin of 7.61% and a return on equity of 2.34%. The company had revenue of $230.11 million during the quarter, compared to analysts’ expectations of $219.39 million. During the same period last year, the business earned $0.38 earnings per share. The company’s quarterly revenue was up 24.7% on a year-over-year basis. Sell-side analysts anticipate that Sabra Healthcare REIT, Inc. will post 1.52 EPS for the current fiscal year.

Sabra Healthcare REIT Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Monday, August 31st. Investors of record on Friday, August 14th were given a $0.30 dividend. The ex-dividend date of this dividend was Friday, August 14th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 5.8%. Sabra Healthcare REIT’s dividend payout ratio is 461.54%.

Institutional Trading of Sabra Healthcare REIT

Hedge funds have recently added to or reduced their stakes in the stock. Rothschild Investment LLC boosted its position in Sabra Healthcare REIT by 164.6% during the fourth quarter. Rothschild Investment LLC now owns 1,429 shares of the real estate investment trust’s stock worth $27,000 after purchasing an additional 889 shares in the last quarter. Smartleaf Asset Management LLC raised its position in Sabra Healthcare REIT by 97.7% during the fourth quarter. Smartleaf Asset Management LLC now owns 1,445 shares of the real estate investment trust’s stock worth $27,000 after acquiring an additional 714 shares during the last quarter. Versant Capital Management Inc lifted its holdings in shares of Sabra Healthcare REIT by 70.0% in the second quarter. Versant Capital Management Inc now owns 1,465 shares of the real estate investment trust’s stock valued at $29,000 after purchasing an additional 603 shares in the last quarter. Danske Bank A S acquired a new stake in shares of Sabra Healthcare REIT in the third quarter valued at approximately $30,000. Finally, Larson Financial Group LLC increased its stake in shares of Sabra Healthcare REIT by 42.3% during the 3rd quarter. Larson Financial Group LLC now owns 1,860 shares of the real estate investment trust’s stock worth $35,000 after purchasing an additional 553 shares in the last quarter. 99.40% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several research firms have recently weighed in on SBRA. Raymond James Financial raised Sabra Healthcare REIT from an “underperform” rating to a “market perform” rating in a report on Thursday, August 6th. Wall Street Zen raised shares of Sabra Healthcare REIT from a “sell” rating to a “hold” rating in a report on Sunday, June 28th. Weiss Ratings downgraded shares of Sabra Healthcare REIT from a “buy (b)” rating to a “hold (c+)” rating in a research report on Tuesday, August 4th. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating on shares of Sabra Healthcare REIT in a research note on Wednesday, July 22nd. Finally, Citizens Jmp raised their price objective on shares of Sabra Healthcare REIT from $23.00 to $25.00 and gave the stock a “market outperform” rating in a research report on Wednesday, July 22nd. Six analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company. According to data from MarketBeat.com, Sabra Healthcare REIT currently has a consensus rating of “Hold” and a consensus price target of $22.17.

About Sabra Healthcare REIT

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net?lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long?term, triple?net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post?acute rehabilitation and research and development laboratories.